{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": 53
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The A53T mutation is known to cause early-onset PD both in humans and in transgenic mice.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines that A53T mutation leads to early-onset PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Kinetic measurements by ThT fluorescence experiments show that the identity of the N-terminal substitution A53T plays a key role in controlling growth rates.",
          "judgment": "Yes",
          "reasoning": "The ThT fluorescence assay is widely used to study fibril formation and is appropriate for assessing the impact of A53T on αSyn aggregation."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "All eight variants were measured at the same time and normalized data were used to determine the mean and standard deviation of the apparent growth rate and the lag time of each variant.",
          "judgment": "Yes",
          "reasoning": "The study includes multiple replicates and normalization, ensuring reliability of the results."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The growth rates can be divided into two groups: one group contains the human A53 residue at the N-terminal and has slower growth rates; a second group contains the mouse T53 residue and has faster growth rates.",
          "judgment": "Yes",
          "reasoning": "Statistical analysis supports the conclusion that A53T mutation significantly increases the growth rate of fibril formation."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The A53T mutation significantly increases the growth rate of αSyn fibril formation, supporting its classification as pathogenic. The functional evidence from ThT fluorescence assays provides moderate strength for this classification."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "S",
          "alt": "N",
          "position": 87
        },
        "variant_string_id": "SNCA S87N"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The NAC region at position 87 has been shown in our studies to be a second key residue in minimizing the duration of the lag phase.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines that S87N mutation impacts the lag phase of αSyn aggregation."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Kinetic measurements by ThT fluorescence experiments show that the identity of the N-terminal substitution A53T and the NAC S87N substitution in synergy play a role in modulating the lag time.",
          "judgment": "Yes",
          "reasoning": "The ThT fluorescence assay is appropriate for assessing the impact of S87N on αSyn aggregation."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "All eight variants were measured at the same time and normalized data were used to determine the mean and standard deviation of the apparent growth rate and the lag time of each variant.",
          "judgment": "Yes",
          "reasoning": "The study includes multiple replicates and normalization, ensuring reliability of the results."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The lag time results are consistent with the previous observation that mouse αSyn has a much shorter lag time than human αSyn and human A53T.",
          "judgment": "Yes",
          "reasoning": "Statistical analysis supports the conclusion that S87N mutation significantly shortens the lag phase of fibril formation."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The S87N mutation significantly shortens the lag phase of αSyn fibril formation, supporting its classification as pathogenic. The functional evidence from ThT fluorescence assays provides supporting strength for this classification."
    }
  ]
}